Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | -20.00% | -83.02% | 59.09% | -12.00% | -9.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.00% | -83.02% | 59.09% | -12.00% | -9.09% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -20.00% | -83.02% | 59.09% | -12.00% | -9.09% |
| SG&A Expenses | -31.20% | -25.75% | 2.40% | 3.21% | 1.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.56% | -4.26% | -23.87% | -2.72% | -7.38% |
| Operating Income | 7.51% | 3.39% | 24.04% | 2.69% | 7.38% |
| Income Before Tax | -3.02% | 3.93% | 15.35% | -7.40% | 0.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.02% | 3.93% | 15.35% | -7.40% | 0.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.02% | 3.93% | 15.35% | -7.40% | 0.00% |
| EBIT | 7.51% | 3.39% | 24.04% | 2.69% | 7.38% |
| EBITDA | 7.58% | 2.67% | 23.70% | 1.98% | 6.68% |
| EPS Basic | -2.77% | 4.57% | 16.36% | -2.77% | 5.80% |
| Normalized Basic EPS | -3.49% | -8.50% | 16.33% | -2.73% | 6.42% |
| EPS Diluted | -2.77% | 4.57% | 16.36% | -2.77% | 5.80% |
| Normalized Diluted EPS | -3.49% | -8.50% | 16.33% | -2.73% | 6.42% |
| Average Basic Shares Outstanding | 0.26% | 0.64% | 1.23% | 4.46% | 6.12% |
| Average Diluted Shares Outstanding | 0.26% | 0.64% | 1.23% | 4.46% | 6.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |